Novai Company

Novai is a disruptive British biotech start-up with an AI supported retinal biomarker for use in glaucoma and AMD clinical trials.

Last Funding Type: Seed
Funding Status: Seed
Headquarters: Reading, Reading, United Kingdom
Founded Date: 2020-02-12
Last Funding Date: 2023-01-24
Total Funding: 5328528
Employee Number: 11-50
Investors Number: 2
Industry: Aging Biomarkers